Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso… - Clinical Cancer …, 2015 - AACR
Purpose: Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral
neuropathies leading to dose reductions and treatment suspensions and decreasing the …
被引用次数：84 相关文章
[PDF] archive.org

[PDF][PDF] Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso… - scholar.archive.org
Purpose: Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral
neuropathies leading to dose reductions and treatment suspensions and decreasing the …

Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.

M Apellániz-Ruiz, MY Lee… - … Cancer Research: an …, 2014 - europepmc.org
Purpose Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral
neuropathies leading to dose reductions and treatment suspensions and decreasing the …

[引用][C] Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy

M Apellániz-Ruiz, MY Lee… - Clinical Cancer …, 2014 - produccioncientifica.ucm.es

Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy

M Apellániz-Ruiz, MY Lee… - … : an official journal …, 2015 - pubmed.ncbi.nlm.nih.gov
Purpose Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral
neuropathies leading to dose reductions and treatment suspensions and decreasing the …
[PDF] academia.edu

[PDF][PDF] Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso… - Clin Cancer …, 2015 - academia.edu
Purpose: Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral
neuropathies leading to dose reductions and treatment suspensions and decreasing the …

Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso… - Clinical Cancer …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Paclitaxel, a widely used
chemotherapeutic drug, can cause peripheral neuropathies leading to dose reductions and …
[PDF] academia.edu

[PDF][PDF] Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso… - Clin Cancer …, 2015 - academia.edu
Purpose: Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral
neuropathies leading to dose reductions and treatment suspensions and decreasing the …